The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(2-((4-((4-amino-2-methylquinolin-6-yl)amino)-6-methylpyrimidin-2-yl)(ethyl)amino)ethyl)-3-(4-(tert-butyl)phenyl)urea ID: ALA5284371
Max Phase: Preclinical
Molecular Formula: C30H38N8O
Molecular Weight: 526.69
Associated Items:
Names and Identifiers Canonical SMILES: CCN(CCNC(=O)Nc1ccc(C(C)(C)C)cc1)c1nc(C)cc(Nc2ccc3nc(C)cc(N)c3c2)n1
Standard InChI: InChI=1S/C30H38N8O/c1-7-38(15-14-32-29(39)36-22-10-8-21(9-11-22)30(4,5)6)28-34-20(3)17-27(37-28)35-23-12-13-26-24(18-23)25(31)16-19(2)33-26/h8-13,16-18H,7,14-15H2,1-6H3,(H2,31,33)(H2,32,36,39)(H,34,35,37)
Standard InChI Key: YKDQMVWTDBOGBF-UHFFFAOYSA-N
Molfile:
RDKit 2D
39 42 0 0 0 0 0 0 0 0999 V2000
-7.1402 -1.4454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4257 -1.0328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.7095 -1.4408 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.9997 -1.0291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2821 -1.4432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5725 -1.0266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5725 -0.2058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8580 0.2065 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.1436 -0.2058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1436 -1.0343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4272 -1.4424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4272 -2.2674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7171 -1.0306 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.7171 -0.2054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0027 0.2069 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.7116 -0.2054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4261 0.2069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1405 -0.2054 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.8549 0.2069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5694 -0.2054 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.2838 0.2069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2838 1.0319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9967 1.4425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7114 1.0299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7114 0.2090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0013 -0.2072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4258 1.4424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4258 2.2674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1402 1.0299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1402 1.8549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8549 1.0319 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.0027 1.0319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7116 1.4444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4290 0.2064 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.2872 0.2065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9997 -0.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.7114 0.2074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4257 -0.2046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.7114 1.0324 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
11 13 1 0
13 14 2 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
22 21 2 0
23 22 1 0
24 23 2 0
25 24 1 0
26 25 2 0
21 26 1 0
24 27 1 0
27 28 1 0
27 29 1 0
27 30 1 0
19 31 2 0
15 32 1 0
32 33 1 0
14 34 1 0
34 9 2 0
7 35 2 0
36 35 1 0
4 36 2 0
36 37 1 0
37 38 2 0
38 2 1 0
37 39 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 526.69Molecular Weight (Monoisotopic): 526.3169AlogP: 5.91#Rotatable Bonds: 8Polar Surface Area: 121.09Molecular Species: BASEHBA: 7HBD: 4#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 5#RO5 Violations (Lipinski): 2CX Acidic pKa: 13.87CX Basic pKa: 8.97CX LogP: 5.29CX LogD: 3.80Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.23Np Likeness Score: -1.57
References 1. Van de Walle T, Cools L, Mangelinckx S, D'hooghe M.. (2021) Recent contributions of quinolines to antimalarial and anticancer drug discovery research., 226 [PMID:34655985 ] [10.1016/j.ejmech.2021.113865 ]